MedTrace Logo

Symptom Tracking in Long COVID Patients Using Formula C™ Sublingual Drops

NCT06163690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-02-25

No results posted yet for this study

Summary

This is a digital symptom tracking study of Formula C™, a full cannabis flower formulation, rich in cannabinoids and terpenes, that has been shown to improve symptoms in people with Long COVID. Participants 21 and older will take Formula C™ for 90 days. During that time, participants will answer weekly surveys to track symptoms and wellbeing.

Conditions

  • Long COVID
  • Long Covid19
  • Post-Acute COVID-19
  • Post-Acute COVID-19 Syndrome
  • Long Haul COVID
  • Long-Haul COVID-19

Interventions

COMBINATION_PRODUCT

Endourage Targeted Wellness Formula C™, a full hemp flower extract

A hemp-derived formulation designed as a daily use adjunctive therapy to help improve Long COVID symptoms. Endourage Targeted Wellness Formula C™ are used as sublingual drops held under the tongue for 60 to 90 seconds.

Sponsors & Collaborators

  • Endourage, LLC

    lead INDUSTRY

Principal Investigators

  • Michael Steward, MD · Endourage, LLC

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-13
Primary Completion
2024-12-02
Completion
2025-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06163690 on ClinicalTrials.gov